Year: 2008
Type: article
Abstract: Coronary heart disease, stroke, diabetes mellitus, hypertension, cancer, depression schizophrenia, Alzheimer's disease, and collagen vascular diseases are low-grade systemic inflammatory conditions that are a severe burden on health care resources. Essential fatty acids (EFAs) and their metabolites: eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), gamma-linolenic acid (GLA), dihomo-gamma-linolenic acid (DGLA), and arachidonic acid (AA) and their products: prostaglandin E1, prostacyclin, lipoxins, resolvins, and protectins suppress inflammation, augment healing, and are of benefit in the prevention and management of these conditions. Hence, supplementation of EFAs could reduce burden of these disease(s).
Source: Lipids in Health and Disease
Author: Undurti N Das
Language: English
Subfield: Nutrition and Dietetics
Field: Nursing
Domain: Health Sciences
Keywords: essential fatty acids, omega-3 fatty acids, eicosapentaenoic acid, docosahexaenoic acid, gamma-linolenic acid, arachidonic acid, anti-inflammatory activity, disease burden, coronary artery disease, stroke, diabetes mellitus, hypertension, cancer, depression, Alzheimer's disease, connective tissue diseases, fatty acid supplementation, eicosanoids
Open Access status: gold
Estimated APC paid: $2,990
OpenAlex ID: W2164086031
